DIATHEVA is an Italian biotech company founded in 2002 with the aim to bring research into industrial products by cooperating with firms, public and private research institutions.
DIATHEVA focuses on development, production and marketing of new and innovative products (antibodies, recombinant proteins, immunoassays and SNPs detection kits) for diagnostics, research and therapeutic applications in the field of: Cancer, Microbial Infection and Pharmacogenetics.
DIATHEVA has a GMP authorized facility designed for the manufacture of APIs for pre-clinical and clinical trial studies with a special emphasis on new immunogens against HIV and other microbial pathogens
A recent paper published in the prestigious scientific journal Clinical Cancer Research entitled “CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin”...Read more
From now on DIATHEVA intends to support your innovative research with minimal financial risk to you. If you are interested in using one of our products in untested applications, species...Read more